Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CRON - Cronos Group Inc


IEX Last Trade
2.27
0.070   3.084%

Share volume: 629,430
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$2.20
0.07
3.18%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
20%
Profitability 0%
Dept financing 1%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-3.42%
1 Month
-7.00%
3 Months
-9.60%
6 Months
0   0%
1 Year
20.86%
2 Year
-23.91%
Key data
Stock price
$2.27
P/E Ratio 
-15.04
DAY RANGE
N/A - N/A
EPS 
-$0.15
52 WEEK RANGE
$1.70 - $3.14
52 WEEK CHANGE
$0.15
MARKET CAP 
863.954 M
YIELD 
N/A
SHARES OUTSTANDING 
382.281 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
1.29
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$834,291
AVERAGE 30 VOLUME 
$1,033,589
Company detail
CEO:
Region: US
Website: https://thecronosgroup.com/
Employees: 456
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.

Recent news